Search research articles
Contact Us
Filters
Showing results (31-40 of 119) with videos related to
Page
of 12
Sort By:
Nutrition Journal
|
April 19, 2015
A review of the systematic review process and its applicability for use in evaluating evidence for health claims on probiotic foods in the European Union
Julie Glanville, Sarah King, Francisco Guarner, et al.
Lancet (London, England)
|
July 16, 2008
Probiotic prophylaxis in predicted severe acute pancreatitis
Gregor Reid, Glenn Gibson, Mary Ellen Sanders, et al.
Inflammatory Bowel Diseases
|
February 7, 2013
Phylogenetic analysis of dysbiosis in ulcerative colitis during remission
Mirjana Rajilić-Stojanović, Fergus Shanahan, Francisco Guarner, et al.
Clinical Chemistry
|
September 9, 2017
Microbiome-Based Diagnostics: Ready for Applications in Laboratory Medicine?
James Versalovic, Joel Dore, Francisco Guarner, et al.
The British Journal of Nutrition
|
July 19, 2005
Should yoghurt cultures be considered probiotic?
Francisco Guarner, Gabriela Perdigon, Gérard Corthier, et al.
International Journal of Molecular Sciences
|
February 15, 2022
Anti-Inflammatory Effect of an <i>O</i>-2-Substituted (1-3)-β-D-Glucan Produced by <i>Pediococcus parvulus</i> 2.6 in a Caco-2 PMA-THP-1 Co-Culture Model
Sara Notararigo, Encarnación Varela, Anna Otal, et al.
Journal of Clinical Gastroenterology
|
July 12, 2014
Digestive Symptoms in Healthy People and Subjects With Irritable Bowel Syndrome: Validation of Symptom Frequency Questionnaire
Fernando Azpiroz, Denis Guyonnet, Yves Donazzolo, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
October 21, 2015
Galectin-4 interacts with the drug transporter human concentrative nucleoside transporter 3 to regulate its function
Paula Fernández-Calotti, Olga Casulleras, María Antolin, et al.
Advances in Therapy
|
January 29, 2024
Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis?
Dan Waitzberg, Francisco Guarner, Iva Hojsak, et al.
Journal of Crohn'S & Colitis
|
March 9, 2012
Restoration of quality of life of patients with inflammatory bowel disease after one year with antiTNFα treatment
Francesc Casellas, Virginia Robles, Natalia Borruel, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 119) with videos related to
Sort By:
Page
of 12
Nutrition Journal
|
April 19, 2015
A review of the systematic review process and its applicability for use in evaluating evidence for health claims on probiotic foods in the European Union
Julie Glanville, Sarah King, Francisco Guarner, et al.
Lancet (London, England)
|
July 16, 2008
Probiotic prophylaxis in predicted severe acute pancreatitis
Gregor Reid, Glenn Gibson, Mary Ellen Sanders, et al.
Inflammatory Bowel Diseases
|
February 7, 2013
Phylogenetic analysis of dysbiosis in ulcerative colitis during remission
Mirjana Rajilić-Stojanović, Fergus Shanahan, Francisco Guarner, et al.
Clinical Chemistry
|
September 9, 2017
Microbiome-Based Diagnostics: Ready for Applications in Laboratory Medicine?
James Versalovic, Joel Dore, Francisco Guarner, et al.
The British Journal of Nutrition
|
July 19, 2005
Should yoghurt cultures be considered probiotic?
Francisco Guarner, Gabriela Perdigon, Gérard Corthier, et al.
International Journal of Molecular Sciences
|
February 15, 2022
Anti-Inflammatory Effect of an <i>O</i>-2-Substituted (1-3)-β-D-Glucan Produced by <i>Pediococcus parvulus</i> 2.6 in a Caco-2 PMA-THP-1 Co-Culture Model
Sara Notararigo, Encarnación Varela, Anna Otal, et al.
Journal of Clinical Gastroenterology
|
July 12, 2014
Digestive Symptoms in Healthy People and Subjects With Irritable Bowel Syndrome: Validation of Symptom Frequency Questionnaire
Fernando Azpiroz, Denis Guyonnet, Yves Donazzolo, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
October 21, 2015
Galectin-4 interacts with the drug transporter human concentrative nucleoside transporter 3 to regulate its function
Paula Fernández-Calotti, Olga Casulleras, María Antolin, et al.
Advances in Therapy
|
January 29, 2024
Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis?
Dan Waitzberg, Francisco Guarner, Iva Hojsak, et al.
Journal of Crohn'S & Colitis
|
March 9, 2012
Restoration of quality of life of patients with inflammatory bowel disease after one year with antiTNFα treatment
Francesc Casellas, Virginia Robles, Natalia Borruel, et al.
Page
of 12